SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-23-012932
Filing Date
2023-04-25
Accepted
2023-04-25 16:10:34
Documents
6
Period of Report
2023-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2023def14a.htm DEF 14A 811586
2 adamsignature.jpg GRAPHIC 11446
3 cap4.jpg GRAPHIC 47231
4 loss3graph.jpg GRAPHIC 52062
5 proxycard1.jpg GRAPHIC 86829
6 proxycard3.jpg GRAPHIC 161354
  Complete submission text file 0001628280-23-012932.txt   1285884
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38295 | Film No.: 23844974
SIC: 2836 Biological Products, (No Diagnostic Substances)